Antinociceptive effect of three common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 3, 2010, Pages 331-337

  Pascual, David ^a   Goicoechea, Carlos ^a   Burgos, Elisa ^a   Martín, María Isabel ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Animal models; Neuropathic pain; NMDA receptors; Opioids; Paclitaxel

Indexed keywords

KETAMINE; METHADONE; MORPHINE; NALOXONE; PACLITAXEL; ANALGESIC AGENT;

ADD ON THERAPY; ALLODYNIA; ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; TACTILE STIMULATION; WEIGHT GAIN; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PROCEDURES; TOXICITY; WISTAR RAT;

ANALGESICS; ANIMALS; MALE; PACLITAXEL; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 77950458300     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.02.009     Document Type: Article

References (61)

1. Andersen G., Sjøgren P., Hansen S.H., Jensen N.H., Christrup L. Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain. Eur J Pain 2004, 8:263-271.
2. Axelrod D.J., Reville B. Using methadone to treat opioid-induced hyperalgesia and refractory pain. J Opioid Manage 2007, 3:113-114.
3. Bennett G.J., Hargreaves K.M. Reply to Hirata and his colleagues. Pain 1990, 42:255.
4. Bilsky E.J., Inturrisi C.E., Sadee W., Hruby V.J., Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice. Pain 1996, 68:229-237.
5. Bulka A., Plesan A., Xu X.J., Wiesenfeld-Hallin Z. Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy. Pain 2002, 95:103-109.
6. Burgess F.W., Pawasauskas J. Methadone analgesia for persistent pain: safety and toxicity considerations. Med Health R I 2008, 91:273-275.
7. Buvanendran A., Kroin J.S. Early use of memantine for neuropathic pain. Anesth Analg 2008, 107:1093-1094.
8. Cata J.P., Weng H.R., Chen J.H., Dougherty P.M. Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience 2006, 138(1):329-338.
9. Cata J.P., Weng H.R., Dougherty P.M. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 2008, 1229:100-110.
10. Cella D., Peterman A., Hudgens S., Webster K., Socinski M.A. Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane). Cancer 2003, 98:822-831.
11. Chizh B.A., Headley P.M. NMDA antagonists and neuropathic pain-multiple drug targets and multiple uses. Curr Pharm Des 2005, 11:2977-2994.
12. Christoph T., Schiene K., Englberger W., Parsons C.G., Chizh B.A. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism. Neuropharmacology 2006, 51:12-17.
13. De Vry J., Kuhl E., Franken-Kunkel P., Eckel G. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol 2004, 491:137-148.
14. Dougherty P.M., Cata J.P., Cordella J.V., Burton A., Weng H.R. Taxol-induced sensory disturbances is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004, 109:132-142.
15. Du J., Koltzenburg M., Carlton S.M. Glutamate-induces excitation and sensitization of nociceptors in rat glabrous skin. Pain 2001, 89:187-198.
16. Ebert B., Andersen S., Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett 1995, 187:165-168.
17. Eide P.K. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain 2000, 4:5-15.
18. Eisenberg E., McNicol E.D., Carr D.B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005, 293:3043-3052.
19. Erichsen H.K., Hao J.X., Xu X.J., Blackburn-Munro G. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain. Pain 2005, 116:347-358.
20. Finkel J.C., Pestieau S.R., Quezado Z.M. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain 2007, 8:515-521.
21. Fischer B.D., Carrigan K.A., Dykstra L.A. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J Pain 2005, 6(7):425-433.
22. Flatters S.J., Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004, 109:150-161.
23. Flatters S.J., Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 2006, 122(3):245-257.
24. Flatters S.J., Xiao W.H., Bennett G.J. Acetyl-l-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 2006, 397(3):219-223.
25. Fox A., Kesingland A., Gentry C., McNair K., Patel S., Urban L., et al. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 2001, 92:91-100.
26. Glare P., Walsh D., Sheehan D. The adverse effects of morphine: a prospective survey of common symptoms during repeated dosing for chronic cancer pain. Am J Hosp Palliat Care 2006, 23:229-235.
27. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl- -aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990, 518:218-226.
28. Hama A., Basler A., Sagen J. Enhancement of morphine antinociception with the peptide N-methyl-d-aspartate receptor antagonist [Ser1]-histogranin in the rat formalin test. Brain Res 2006, 1095:59-64.
29. Haugan F., Rygh L.J., Tjølsen A. Ketamine blocks enhancement of spinal long-term potentiation in chronic opioid treated rats. Acta Anaesthesiol Scand 2008, 52:681-687.
30. Holtman J.R., Crooks P.A., Johnson-Hardy J., Wala E.P. Interaction between morphine and norketamine enantiomers in rodent models of nociception. Pharmacol Biochem Behav 2008, 90:769-777.
31. Inturrisi C.E. Pharmacology of methadone and its isomers. Minerva Anesthesiol 2005, 71:435-437.
32. Kawashiri T., Egashira N., Itoh Y., Shimazoe T., Ikegami Y., Yano T., et al. Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy. Eur J Cancer 2009, 45(1):154-163.
33. Kollender Y., Bickels J., Stocki D., Maruoani N., Chazan S., Nirkin A., et al. Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic-oncological patients. Eur J Cancer 2008, 44:954-962.
34. Lemberg K., Kontinen V.K., Viljakka K., Kylänlahti I., Yli-Kauhaluoma J., Kalso E. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat. Anesth Analg 2006, 102:1768-1774.
35. Mannino R., Coyne P., Swainey C., Hansen L.A., Lyckholm L. Methadone for cancer-related neuropathic pain: a review of the literature. J Opioid Manage 2006, 2:269-276.
36. Martinez V., Christensen D., Kayser V. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats. Pain 2002, 99:537-545.
37. Matsumoto M., Inoue M., Hald A., Xie W., Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 2006, 318(2):735-740.
38. Nozaki-Taguchi N., Chaplan S.R., Higuera E.S., Ajakwe R.C., Yaksh T.L. Vincristine-induced allodynia in the rat. Pain 2001, 93:69-73.
39. Obara I., Makuch W., Spetea M., Schütz J., Schmidhammer H., Przewlocki R., et al. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur J Pharmacol 2007, 558:60-67.
40. Ossipov M.H., Bian D., Malan T.P., Lai J., Porreca F. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain 1999, 79:127-133.
41. Ossipov M.H., Lai J., Malan T.P., Porreca F. Opioid analgesic activity in neuropathic pain states. Progress in pain research and management 1999, 14:163-182. IASP Press, Seattle, WA. E. Kalso, H. McQuay, Z. Wiesenfeld-Hallin (Eds.).
42. Pascual D., Goicoechea C., Suardiaz M., Martin M.I. A cannabinoid agonist, WIN 55, 212-2, reduces neuropathic nociception induced by paclitaxel in rats. Pain 2005, 118:23-34.
43. Pelissier T., Laurido C., Kramer V., Hernandez A., Paeile C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats. Eur J Pharmacol 2003, 477:23-28.
44. Peng P., Tumber P., Stafford M., Gourlay D., Wong P., Galonski M., et al. Experience of methadone therapy in 100 consecutive chronic pain patients in a multidisciplinary pain center. Pain Med 2008, 9:786-794.
45. Persson J., Hasselström J., Maurset A., Oye I., Svensson J.O., Almqvist O., et al. Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity. Eur J Clin Pharmacol 2002, 57:869-875.
46. Polomano R.C., Mannes A.J., Clark U.S., Bennet G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 2001, 94:293-304.
47. Przewlocki R., Przewlocka B. Opioids in neuropathic pain. Curr Pharm Des 2005, 11:3013-3025.
48. Quasthoff S., Hartung H.P. Chemotherapy-induced peripheral neuropathy. J Neurol 2002, 249:9-17.
49. Rowbotham M.C., Twilling L., Davies P.S., Reisner L., Taylor K., Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003, 348:1223-1232.
50. Rowinsky E.K., Cazenave L.A., Donehower R.C. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 1990, 82:1247-1259.
51. Sakurai M., Egashira N., Kawashiri T., Yano T., Ikesue H., Oishi R. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain 2009, 147(1-3):165-174.
52. Sartain J.B., Mitchell S.J. Successful use of oral methadone after failure of intravenous morphine and ketamine. Anaesth Intensive Care 2002, 30:487-489.
53. Sevostianova N., Danysz W., Bespalov A.Y. Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists. Eur J Pharmacol 2005, 525:83-90.
54. Shaiova L. The role of methadone in the treatment of moderate to severe cancer pain. Support Cancer Ther 2005, 2:176-180.
55. Shir Y., Seltzer Z. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett 1998, 115:62-67.
56. Subramaniam K., Subramaniam B., Steinbrook R.A. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004, 99:482-495.
57. Tian Y.L., Guo Y., Cao D.Y., Zhang Q., Wang H.S., Zhao Y. Local application of morphine suppresses glutamate-evoked activities of C and Adelta afferent fibers in rat hairy skin. Brain Res 2005, 1059:28-34.
58. Vera G., Chiarlone A., Cabezos P.A., Pascual D., Martín M.I., Abalo R. WIN 55, 212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat. Life Sci 2007, 81(6):468-479.
59. Xiao W.H., Bennett G.J. Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitine. Pain 2008, 135:262-270.
60. Xiao W., Naso L., Bennett G.J. Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies. Pain Med 2008, 9(5):505-517.
61. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.